Ursodeoxycholic acid (UDCA) is widely used for the treatment of chronic cholestatic liver diseases. However, a recent randomized, controlled trial has surprisingly shown that the use of high-dose ...

原发性硬化性胆管炎(Primary Sclerosing Cholangitis，PSC)是一种慢性胆汁淤积性肝病，其特征是胆管炎症和纤维化导致的胆管狭窄，最终可进展为肝硬化、肝衰竭。

Effective therapy for NASH is still lacking. In this study, we investigated the effects of Ursodeoxycholic acid (UDCA) in the treatment of NASH. Methods: Western and Chinese databases were ...

Discover all the brand names or Trade names of generic drug called Ursodeoxycholic Acid. This serves as a crucial reference for healthcare professionals, patients, caregivers, and anyone looking ...

UK MHRA grants marketing approval for Ipsen’s elafibranor to treat adults with rare liver disease known as PCB: United Kingdom Thursday, October 10, 2024, 15:00 Hrs [IST] The Me ...

Ipsen has received the UK Medicines and Healthcare products Regulatory Agency (MHRA) approval for its Elafibranor (Iqirvo) ...

Primary biliary cholangitis (PBC), previously referred to as primary biliary cirrhosis, is a long-term liver condition ...

Sun Pharma, Torrent Pharma, and other drug companies have refuted claims from the CDSCO report that flagged over 50 medicines ...

Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the European Commission has conditionally approved Iqirvo ® (elafibranor) 80mg tablets for the treatment of primary biliary cholangitis (PBC) in ...

(RTTNews) - Ipsen (IPSEY) announced the European Commission has conditionally approved Iqirvo 80mg tablets for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid ...

The shares of one of the leading pharma engaged in manufacturing API, Formulation, and Development services rose 3.7% after ...

For cholesterol gallstones, medications like ursodeoxycholic acid can be prescribed, although this method may take months or ...